Search company, investor...



Seed VC | Alive

Total Raised


Last Raised

$1.1M | 13 yrs ago

About FluimediX

FluimediX is in the process of developing the NanoCycler device. The NanoCycler is a tabletop device designed to accept a disposable polymer cartridge, in which a number of biochemical reactions are performed on a human saliva sample. The NanoCycler will deliver an identification of the presence of - respectively lack of - a number of genetic mutations; the so-called SNPs - Single Nucleotide Polymorphisms.

Headquarters Location

Gregersensvej, building 6



Missing: FluimediX's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: FluimediX's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

FluimediX Patents

FluimediX has filed 1 patent.

patents chart

Application Date

Grant Date


Related Topics




Fluid dynamics, Fluid mechanics, Aerodynamics, Continuum mechanics, Flow meters


Application Date


Grant Date



Related Topics

Fluid dynamics, Fluid mechanics, Aerodynamics, Continuum mechanics, Flow meters



FluimediX Frequently Asked Questions (FAQ)

  • What is FluimediX's latest funding round?

    FluimediX's latest funding round is Seed VC.

  • How much did FluimediX raise?

    FluimediX raised a total of $1.1M.

  • Who are the investors of FluimediX?

    Investors of FluimediX include SEED Capital.

  • Who are FluimediX's competitors?

    Competitors of FluimediX include Neuros Medical, Moximed, SynCardia Systems, Tepha, HemoShear Therapeutics, Rheonix, Lucina Health, Zipline Medical, Paragon Medical, Elastagen and 18 more.

Compare FluimediX to Competitors


C2C is a medical device company developing a portfolio of medical devices.


Aksys has developed an automated personal hemodialysis system for patient-performed hemodialysis in alternative care settings such as the patient's home.

Moximed Logo

Moximed develops unicompartmental load absorber implants for active patients with painful knee osteoarthritis (OA). The company offers an implant procedure that do not require bone cutting or bone removal, and, importantly, they absorb excess joint load rather than shift load to other areas of the joint. The company was founded in 2006 and is based in Fremont, California.


NeuroTrax is a medical device and technology company.

SpringMed Group

The resources necessary to transform a medical device concept into a commercially viable reality are enormous. Appropriate funding in addition to Food and Drug Administration ( FDA) experience, engineering and rapid prototyping are essential in order to have any reasonable chance for success. To this end, SpringMed Group is a medical device business accelerator that has been designed and organized around core competencies that will substantially improve the development time line and successful launch of new and medical devices.

Serica Technologies

Serica is a medical device company focused on the development of silk-based biomaterial platforms that may be used in tissue repair. The company's approach leverages natural silk in combination with advances in biomedical engineering to address needs in the repair of damaged connective tissue, caused by disease, trauma, or aging. Serica's products are being studied for use in orthopaedics and sports medicine, aesthetic and reconstructive plastic surgery, and multiple additional structural tissue repair applications.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.